Crohn's Disease: Myths, Facts, and What Modern Treatment Looks Like

Crohn's disease has a reputation — and not always an accurate one. Patients newly diagnosed with Crohn's often come to us with a set of fears and assumptions gathered from online searches, well-meaning relatives, and outdated information. The good news is that the treatment landscape for Crohn's disease has been transformed over the past two decades, and with proper management, most patients can achieve and maintain remission.

Let's separate the myths from the facts.

Myth: Crohn's Disease Only Affects the Colon

Fact: Crohn's disease can affect any part of the gastrointestinal tract from the mouth to the anus. The most common location is the terminal ileum (the end of the small intestine) and the colon, but Crohn's can also involve the stomach, duodenum, esophagus, and perianal region. This is one of the key features that distinguishes Crohn's from ulcerative colitis, which is limited to the colon.

Myth: Diet Causes Crohn's Disease

Fact: No specific food causes Crohn's disease. Crohn's is an autoimmune condition — the immune system mistakenly attacks the GI tract, triggering chronic inflammation. That said, certain foods can worsen symptoms during a flare, and dietary modifications are often part of a comprehensive management plan. A registered dietitian can help identify personal trigger foods without unnecessary dietary restriction.

Myth: Crohn's Disease Always Requires Surgery

Fact: Surgery is required in some Crohn's patients — particularly those who develop complications like strictures, fistulas, or abscesses that don't respond to medical therapy. But with modern biologic treatments, many patients can avoid or delay surgery. The goal of medical therapy is to achieve deep remission: no symptoms, no inflammation on endoscopy, and normal inflammatory markers.

Myth: Biologic Medications Are Dangerous

Fact: Biologic therapies — including anti-TNF agents like infliximab and adalimumab, vedolizumab, and ustekinumab — have been in widespread clinical use for over 25 years. While they do carry risks (primarily an increased risk of infection), these are carefully monitored and are generally well-tolerated. For most patients with moderate-to-severe Crohn's disease, the benefit of biologics in preventing disease progression, hospitalizations, and surgery far outweighs the risks.

At Advanced Gastroenterology Group, we offer in-office IV infusions for patients on vedolizumab and infliximab — a significant convenience compared to hospital infusion centers.

Myth: Crohn's Disease Means a Life of Restriction and Suffering

Fact: Many patients with Crohn's disease — properly diagnosed and treated — live full, active lives with minimal disruption. The goal of modern IBD care is not just symptom control but mucosal healing: achieving actual remission at the tissue level, which dramatically reduces the risk of complications and disease progression.

The Importance of Regular Monitoring

Crohn's disease requires ongoing specialist care — not just during flares but in remission too. Regular monitoring allows us to assess disease activity, adjust medications before symptoms return, and perform surveillance colonoscopy to screen for dysplasia and colorectal cancer in patients with longstanding colonic involvement.

📅 Newly diagnosed or looking for a second opinion? Our IBD specialists are here to help. Call (908) 851-2770 or book online.

Book an Appointment

Medical Disclaimer: This blog post is intended for general informational and educational purposes only and does not constitute medical advice.